Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cyclo Therapeutics Inc (NQ: CYTH )

0.6772 -0.0528 (-7.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cyclo Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Cyclo Therapeutics Announces Formation of Global Steering Committee Comprised of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for Trappsol® Cyclo™ in Niemann-Pick Disease Type C
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Present at the Virtual Investor 2022 Top Picks Conference
From Cyclo Therapeutics, Inc.
Via Business Wire
4 Penny Stocks Insiders Are Buying: Crexendo, Performant Financial And More
Silver prices surged above $24 per troy ounce for the first time in more than two months and investors also focused on some notable insider... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers ATI Physical Therapy (NYSE:ATIP) stock increased by 22.7% to $3.73 during Friday's regular session. Trading volume for ATI Physical Therapy's stock is 14.3... 
Via Benzinga
JTC Team to Host Virtual Investor 2022 Top Picks Conference on January 25th, 26th, and 27th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast presentations of participating companies followed by interactive Q&A session - PITTSTOWN, NJ /... 
From JTC Team, LLC
Via AccessWire
45 Biggest Movers From Yesterday
Gainers Puxin Limited (NYSE: NEW) shares surged 80% to close at $0.54 on Wednesday after reporting results for the second quarter. United Time Technology Co., Ltd. (NASDAQ: UTME... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Cognition Therapeutics (NASDAQ:CGTX 
Via Benzinga
Cyclo Therapeutics Appoints Caroline Hastings, M.D. as Global Principal Investigator for Ongoing TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Receives IND Clearance from the U.S. FDA to Advance its Phase 2 Study of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease
From Cyclo Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Qualigen Therapeutics (NASDAQ:QLGN 
Via Benzinga
61 Biggest Movers From Yesterday
Gainers Sono Group N.V. (NASDAQ: SEV) shares climbed 154.7% to close at $38.20 on Wednesday after the company priced its IPO at $15 per share. Braze, Inc. (NASDAQ: BRZE) jumped... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Afternoon Market Update: Dow Falls 200 Points; Rockwell Medical Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded down 0.58% to 35,930.89 while the NASDAQ fell 0.27% to 15,930.79. The S&P also fell, dropping 0.23% to 4,690.24. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers EyePoint Pharmaceuticals (NASDAQ:EYP... 
Via Benzinga
Mid-Day Market Update: StoneCo Drops After Q3 Earnings; EyePoint Pharmaceuticals Shares Surge
Midway through trading Wednesday, the Dow traded down 0.51% to 35,958.22 while the NASDAQ rose 0.03% to 15,977.88. The S&P also fell, dropping 0.13% to 4,694.96. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
42 Stocks Moving In Wednesday's Mid-Day Session
Gainers Sono Group N.V. (NASDAQ: SEV) shares jumped 66% to $24.90 after the company priced its IPO at $15 per share. EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares climbed... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Morning Market Update: Markets Down; Lowe's Earnings Beat Estimates
Following the market opening Wednesday, the Dow traded down 0.34% to 36,017.63 while the NASDAQ fell 0.19% to 15,944.13. The S&P also fell, dropping 0.23% to 4,690.06. The U.S... 
Via Benzinga
Topics Earnings Stocks
Exposures Financial US Equities
Cyclo Raises $12M Equity At 18% Discount To Fund Trappsol Development
Cyclo Therapeutics Inc (NASDAQ: CYTH) has priced its previously announced underwritten public offering of 1.95 million shares at $6.00 per share, with gross proceeds of... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Rockwell Medical (NASDAQ:RMTI) shares rose 47.27% to $0.71 during Wednesday's pre-market session. The company's market cap stands at $66.5 million. The... 
Via Benzinga
The Daily Biotech Pulse: Atea Sinks On Termination Of Roche Contract, Pfizer CFO To Retire, GSK-Vir Bag $1B Contract To Supply COVID Antibody Treatment
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Atea Announces Termination of Strategic Collaboration With Roche Atea... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Good morning, trader! We're halfway through the week and with that comes a look at the biggest pre-market stock movers for Wednesday! 
Via InvestorPlace
25 Stocks Moving in Wednesday's Pre-Market Session
Gainers 17 Education & Technology Group Inc. (NASDAQ: YQ) rose 283.5% to $3.16 in pre-market trading. 17 Education & Technology, earlier during the month, reported a $10... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings, Fed Speakers
Pre-open movers U.S. stock futures traded mixed in early pre-market trade after closing mostly flat in the prior session. Investors are awaiting earnings results from Lowe`s... 
Via Benzinga
Topics Economy
Exposures Interest Rates
5 Stocks To Watch For November 17, 2021
Some of the stocks that may grab investor focus today are: Wall Street expects Lowe`s Companies Inc (NYSE: LOW) to report quarterly earnings at $2.35 per share on revenue of $... 
Via Benzinga
Cyclo Therapeutics Announces Pricing of $11.7 Million Underwritten Public Offering of Common Stock
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Announces Proposed Public Offering of Common Stock
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Shares Jump After Filing To Start Alzheimer's Trial In US
Cyclo Therapeutics Inc (NASDAQ: CYTH) has submitted its initial investigational new drug (IND) application with the FDA for a Phase 2 study of Trappsol Cyclo for... 
Via Benzinga
Exposures Product Safety
Cyclo Therapeutics Submits Investigational New Drug Application to U.S. FDA to Advance Trappsol® Cyclo™ in Phase 2 Study for Treatment of Alzheimer’s Disease
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
From Cyclo Therapeutics, Inc.
Via Business Wire
Cyclo Therapeutics to Present at the Virtual Investor Roundtable Event
From Cyclo Therapeutics, Inc.
Via Business Wire
JTC Team to Host Virtual Investor Roundtable Event on November 16th, 17th, and 18th
- Access the event and schedule of presenting companies at virtualinvestorco.com - - Live video webcast roundtable discussions with members of Management and Thought Leaders across participating... 
From JTC Team, LLC
Via AccessWire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.